These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32888223)

  • 1. Alopecia areata treated with dimethyl fumarate: A case series.
    Muscianese M; Magri F; Leoncini PP; Fortuna MC; Caro G; Rossi A
    Dermatol Ther; 2020 Nov; 33(6):e14158. PubMed ID: 32888223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata treated with topical and systemic brevilin A: A case series.
    Muscianese M; Magri F; Leoncini P; Fortuna MC; Caro G; Rossi A
    Dermatol Ther; 2021 Mar; 34(2):e14778. PubMed ID: 33438308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alopecia areata with white hair regrowth: case report and review of poliosis.
    Jalalat SZ; Kelsoe JR; Cohen PR
    Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
    Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
    Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could azathioprine be considered as a therapeutic alternative in the treatment of alopecia areata? A pilot study.
    Farshi S; Mansouri P; Safar F; Khiabanloo SR
    Int J Dermatol; 2010 Oct; 49(10):1188-93. PubMed ID: 20883409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An uncontrolled, open label study of sulfasalazine in severe alopecia areata.
    Aghaei S
    Indian J Dermatol Venereol Leprol; 2008; 74(6):611-3. PubMed ID: 19171984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alopecia areata: more than skin deep.
    MacLean KJ; Tidman MJ
    Practitioner; 2013 Sep; 257(1764):29-32, 3. PubMed ID: 24383154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European expert consensus statement on the systemic treatment of alopecia areata.
    Rudnicka L; Arenbergerova M; Grimalt R; Ioannides D; Katoulis AC; Lazaridou E; Olszewska M; Ovcharenko YS; Piraccini BM; Prohic A; Rakowska A; Reygagne P; Richard MA; Soares RO; Starace M; Vañó-Galvan S; Waskiel-Burnat A
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):687-694. PubMed ID: 38169088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of alopecia areata with Dr. Michaels® (Alopinex) product family.
    Wollina U; Hercogovấ J; Fioranelli M; Gianfaldoni S; Chokoeva AA; Tchernev G; Tirant M; Novotny F; Roccia MG; Maximov GK; França K; Lotti T
    J Biol Regul Homeost Agents; 2016; 30(2 Suppl 3):83-7. PubMed ID: 27498663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the willingness to undergo treatment in patients with alopecia areata.
    O'Connor LF; Wells KM
    Arch Dermatol Res; 2022 Oct; 314(8):749-757. PubMed ID: 34609599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
    Browne R; Stewart L; Williams HC
    Br J Dermatol; 2018 Sep; 179(3):609-614. PubMed ID: 29777625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topographic Phenotypes of Alopecia Areata and Development of a Prognostic Prediction Model and Grading System: A Cluster Analysis.
    Lee S; Kim BJ; Lee CH; Lee WS
    JAMA Dermatol; 2019 May; 155(5):564-571. PubMed ID: 30916724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia areata: A multifactorial autoimmune condition.
    Simakou T; Butcher JP; Reid S; Henriquez FL
    J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe alopecia areata treated with systemic corticosteroids.
    Alabdulkareem AS; Abahussein AA; Okoro A
    Int J Dermatol; 1998 Aug; 37(8):622-4. PubMed ID: 9732014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baricitinib: A Review in Severe Alopecia Areata.
    Fung S; Shirley M
    Am J Clin Dermatol; 2023 Jul; 24(4):661-668. PubMed ID: 37326792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata. Pathogenesis, diagnosis, and therapy.
    Papadopoulos AJ; Schwartz RA; Janniger CK
    Am J Clin Dermatol; 2000; 1(2):101-5. PubMed ID: 11702308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials.
    Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes FP; Dutronc Y; Mesinkovska N; Ko JM; King BA
    Br J Dermatol; 2020 Oct; 183(4):702-709. PubMed ID: 31970750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata treated with hydroxychloroquine: A retrospective study of nine pediatric cases.
    Yun D; Silverberg NB; Stein SL
    Pediatr Dermatol; 2018 May; 35(3):361-365. PubMed ID: 29575039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of alopecia areata: modern principles and perspectives].
    Brajac I; Kastelan M; Perisa D; Simonić E; Stojnić-Sosa L; Massari LP
    Lijec Vjesn; 2010; 132(11-12):365-9. PubMed ID: 21294327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.